Valeo Financial Advisors, LLC Myriad Genetics Inc Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$25.39 - $32.61 $13,025 - $16,728	-513 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$12.16 - $19.77 $2,128 - $3,459	175 Added 51.78%	513 $10,000
Q2 2019 Jul 10, 2019	BUY	$22.67 - $35.0 $3,309 - $5,110	146 Added 76.04%	338 $9,000
Q1 2019 Apr 12, 2019	SELL	$26.93 - $34.7 $4,308 - $5,552	-160 Reduced 45.45%	192 $6,000
Q4 2018 Jan 30, 2019	BUY	$27.23 - $45.56 $2,968 - $4,966	109 Added 44.86%	352 $10,000
Q3 2018 Nov 01, 2018	BUY	$37.57 - $50.34 $3,118 - $4,178	83 Added 51.88%	243 $11,000
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $4,440 - $6,427	160 New	160 $7,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.